Pfizer and Japanese firm Astellas' drug Padcev, combined with Merck's Keytruda, lowered the risk of tumor recurrence, ...

He stipulated that the honoree should be a force for good, and selected Pfizer Chairman Albert Bourla for his innovation, ...

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

Pfizer enters the obesity drug market with a reasonably valued deal, while valuation remains attractive and technicals show ...

Pfizer Inc. is a global biopharmaceutical leader with a diversified product portfolio and significant scale, supported by ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Pfizer CEO Albert Bourla, who was in the Oval Office with the president for the announcement, said Mr. Trump's threat of 100% ...

President Donald Trump announced a deal with Pfizer to lower drug prices for some Americans. The White House is also unveiling a TrumpRx website.

The pharmaceutical giant has granted the president’s long-standing demands. Other drug companies could be next.

One Louisiana woman, Robin Phillip, said she developed an intracranial meningioma that caused her to lose vision in her left ...

Trump and Pfizer said they reached a landmark deal to cut drug prices. Most Americans won't see a benefit, but Pfizer will.

After its best day in nearly four years Tuesday, Pfizer stock gave an encore performance. Shares of the drugmaker closed u ...